The developmental stage determines the distribution and duration of gene expression after early intra-amniotic gene transfer using lentiviral vectors

Gene Therapy

Volumn 17, Issue 1, 2010, Pages 61-71

  Endo, M ^a   Henriques Coelho, T ^a   Zoltick, P W ^a   Stitelman, D H ^a   Peranteau, W H ^a   Radu, A ^a   Flake, A W ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Fetal gene therapy; In utero; Intra amniotic gene transfer; Lentiviral vector

Indexed keywords

GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR;

AMNION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL POPULATION; DEVELOPMENTAL STAGE; ENDODERM; EPITHELIUM CELL; FEMALE; FETUS; GERM LAYER; GESTATION PERIOD; MESODERM; MOLECULAR MECHANICS; MOUSE; NEUROECTODERM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRAL GENE DELIVERY SYSTEM;

AMNION; ANIMALS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GESTATIONAL AGE; LENTIVIRUS; MICE; MICE, INBRED BALB C; TISSUE DISTRIBUTION; TRANSDUCTION, GENETIC;

EID: 74349131596     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2009.115     Document Type: Article

References (55)

1. Iwamoto HS, Trapnell BC, McConnell CJ, Daugherty C, Whitsett JA. Pulmonary inflammation associated with repeated, prenatal exposure to an E1, E3-deleted adenoviral vector in sheep. Gene Therapy 1999; 6: 98-106.
2. Sylvester KG, Yang EY, Cass DL, Crombleholme TM, Adzick NS. Fetoscopic gene therapy for congenital lung disease. J Pediatr Surg 1997; 32: 964-969.
3. Vincent MC, Trapnell BC, Baughman RP, Wert SE, Whitsett JA, Iwamoto HS. Adenovirus-mediated gene transfer to the respiratory tract of fetal sheep in utero. Hum Gene Ther 1995; 6: 1019-1028.
4. Schachtner S, Buck C, Bergelson J, Baldwin H. Temporally regulated expression patterns following in utero adenovirus-mediated gene transfer. Gene Therapy 1999; 6: 1249-1257.
5. Waddington SN, Buckley SM, Bernloehr C, Bossow S, Unger-echts G, Cook Tet al. Reduced toxicity of F-deficient Sendai virus vector in the mouse fetus. Gene Therapy 2004; 11: 599-608.
6. Karolewski BA, Wolfe JH. Genetic correction of the fetal brain increases the lifespan of mice with the severe multi-systemic disease mucopolysaccharidosis type VII. Mol Ther 2006; 14: 14-24.
7. Shen JS, Meng XL, Maeda H, Ohashi T, Eto Y. Widespread gene transduction to the central nervous system by adenovirus in utero: implication for prenatal gene therapy to brain involvement of lysosomal storage disease. J Gene Med 2004; 6: 1206-1215.
8. Christensen G, Minamisawa S, Gruber PJ, Wang Y, Chien KR. High-efficiency, long-term cardiac expression of foreign genes in living mouse embryos and neonates. Circulation 2000; 101: 178-184.
9. Bouchard S, MacKenzie TC, Radu AP, Hayashi S, Peranteau WH, Chirmule N et al. Long-term transgene expression in cardiac and skeletal muscle following fetal administration of adenoviral or adeno-associated viral vectors in mice. J Gene Med 2003; 5: 941-950.
10. Lipshutz GS, Flebbe-Rehwaldt L, Gaensler KM. Adenovirus-mediated gene transfer to the peritoneum and hepatic parenchyma of fetal mice in utero. Surgery 1999; 126: 171-177.
11. Lipshutz GS, Gruber CA, Cao Y, Hardy J, Contag CH, Gaensler KM. In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression. Mol Ther 2001; 3: 284-292.
12. Mitchell M, Jerebtsova M, Batshaw ML, Newman K, Ye X. Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors. Gene Therapy 2000; 7: 1986-1992.
13. Turkay A, Saunders T, Kurachi K. Intrauterine gene transfer: gestational stage-specific gene delivery in mice. Gene Therapy 1999; 6: 1685-1694.
14. Gregory LG, Waddington SN, Holder MV, Mitrophanous KA, Buckley SM, Mosley KL et al. Highly efficient EIAV-mediated in utero gene transfer and expression in the major muscle groups affected by Duchenne muscular dystrophy. Gene Therapy 2004; 11: 1117-1125.
15. Mackenzie TC, Kobinger GP, Kootstra NA, Radu A, Sena-Esteves M, Bouchard S et al. Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes. Mol Ther 2002; 6: 349-358.
16. MacKenzie TC, Kobinger GP, Louboutin JP, Radu A, Javazon EH, Sena-Esteves M et al. Transduction of satellite cells after prenatal intramuscular administration of lentiviral vectors. J Gene Med 2005; 7: 50-58.
17. Weisz B, David AL, Gregory LG, Perocheau D, Ruthe A, Waddington SN et al. Targeting the respiratory muscles of fetal sheep for prenatal gene therapy for Duchenne muscular dystrophy. Am J Obstet Gynecol 2005; 193: 1105-1109.
18. Yang EY, Kim HB, Shaaban AF, Milner R, Adzick NS, Flake AW. Persistent postnatal transgene expression in both muscle and liver after fetal injection of recombinant adenovirus. J Pediatr Surg 1999; 34: 766-772; discussion 772-1763
19. Holzinger A, Trapnell BC, Weaver TE, Whitsett JA, Iwamoto HS. Intraamniotic administration of an adenoviral vector for gene transfer to fetal sheep and mouse tissues. Pediatr Res 1995; 38: 844-850.
20. Larson JE, Morrow SL, Delcarpio JB, Bohm RP, Ratterree MS, Blanchard JL et al. Gene transfer into the fetal primate: evidence for the secretion of transgene product. Mol Ther 2000; 2: 631-639.
21. Larson JE, Morrow SL, Happel L, Sharp JF, Cohen JC. Reversal of cystic fibrosis phenotype in mice by gene therapy in utero. Lancet 1997; 349: 619-620.
22. McCray Jr PB, Armstrong K, Zabner J, Miller DW, Koretzky GA, Couture L et al. Adenoviral-mediated gene transfer to fetal pulmonary epithelia in vitro and in vivo. J Clin Invest 1995; 95: 2620-2632.
23. Buckley SM, Waddington SN, Jezzard S, Lawrence L, Schneider H, Holder MV et al. Factors influencing adenovirus-mediated airway transduction in fetal mice. Mol Ther 2005; 12: 484-492.
24. Schneider H, Adebakin S, Themis M, Cook T, Douar AM, Pavirani A et al. Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B. J Gene Med 1999; 1: 424-432.
25. Douar AM, Adebakin S, Themis M, Pavirani A, Cook T, Coutelle C et al. Foetal gene delivery in mice by intra-amniotic administration of retroviral producer cells and adenovirus. Gene Therapy 1997; 4: 883-890.
26. Boyle MP, Enke RA, Adams RJ, Guggino WB, Zeitlin PL. In utero AAV-mediated gene transfer to rabbit pulmonary epithelium. Mol Ther 2001; 4: 115-121.
27. Ferrari S, Pellegrini G, Mavilio F, De Luca M. Gene therapy approaches for epidermolysis bullosa. Clin Dermatol 2005; 23: 430-436.
28. Endo M, Zoltick PW, Peranteau WH, Radu A, Muvarak N, Ito M et al. Efficient in vivo targeting of epidermal stem cells by early gestational intraamniotic injection of lentiviral vector driven by the keratin 5 promoter. Mol Ther 2008; 16: 131-137.
29. Endo M, Zoltick PW, Chung DC, Bennett J, Radu A, Muvarak N et al. Gene transfer to ocular stem cells by early gestational intraamniotic injection of lentiviral vector. Mol Ther 2007; 15: 579-587.
30. Findlater GS, McDougall RD, Kaufman MH. Eyelid development, fusion and subsequent reopening in the mouse. J Anat 1993; 183(Pt 1): 121-129.
31. Kaufman MH, Bard J. The Anatomical Basis of Mouse Development. Academic Press: San Diego, 1999.
32. Baker CV, Bronner-Fraser M. Vertebrate cranial placodes I. Embryonic induction. Dev Biol 2001; 232: 1-61.
33. Blackburn CC, Manley NR. Developing a new paradigm for thymus organogenesis. Nat Rev Immunol 2004; 4: 278-289.
34. Graw J. The genetic and molecular basis of congenital eye defects. Nat Rev Genet 2003; 4: 876-888.
35. Pispa J, Thesleff I. Mechanisms of ectodermal organogenesis. Dev Biol 2003; 262: 195-205.
36. Hardman MJ, Sisi P, Banbury DN, Byrne C. Patterned acquisition of skin barrier function during development. Development 1998; 125: 1541-1552.
37. M'Boneko V, Merker HJ. Development and morphology of the periderm of mouse embryos (days 9-12 of gestation). Acta Anat (Basel) 1988; 133: 325-336.
38. Byrne C, Hardman M, Nield K. Covering the limb-formation of the integument. J Anat 2003; 202: 113-123.
39. Kaufman MH. The Atlas of Mouse Development. Academic Press: London, San Diego, 1992.
40. Burns AJ. Migration of neural crest-derived enteric nervous system precursor cells to and within the gastrointestinal tract. Int J Dev Biol 2005; 49: 143-150.
41. Solnica-Krezel L. Conserved patterns of cell movements during vertebrate gastrulation. Curr Biol 2005; 15: R213-R228.
42. Sato M, Tanigawa M, Kikuchi N. Nonviral gene transfer to surface skin of mid-gestational murine embryos by intraamnio-tic injection and subsequent electroporation. Mol Reprod Dev 2004; 69: 268-277.
43. Kobayashi K, Lemke RP, Greer JJ. Ultrasound measurements of fetal breathing movements in the rat. J Appl Physiol 2001; 91: 316-320
44. U.S. National Institutes of Health. Recombinant DNA Advisory Committee. Prenatal gene transfer: scientific, medical, and ethical issues: a report of the Recombinant DNA Advisory Committee. Hum Gene Ther 2000; 11: 1211-1229.
45. Miyoshi H, Blömer U, Takahashi M, Gage FH, Verma IM. Development of a self-inactivating lentivirus vector. J Virol 1998; 72: 8150-8157.
46. Naldini L, Blömer U, Gage FH, Trono D, Verma IM. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 1996; 93: 11382-11388.
47. Zennou V, Serguera C, Sarkis C, Colin P, Perret E, Mallet J et al. The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain. Nat Biotechnol 2001; 19: 446-450.
48. Donello JE, Loeb JE, Hope TJ. Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J Virol 1998; 72: 5085-5092.
49. Robbins PB, Yu XJ, Skelton DM, Pepper KA, Wasserman RM, Zhu L et al. Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells. J Virol 1997; 71: 9466-9474.
50. Kozak M. Initiation of translation in prokaryotes and eukaryotes. Gene 1999; 234: 187-208.
51. Sena-Esteves M, Tebbets JC, Steffens S, Crombleholme T, Flake AW. Optimized large-scale production of high titer lentivirus vector pseudotypes. J Virol Methods 2004; 122: 131-139.
52. O'Rourke JP, Hiraragi H, Urban K, Patel M, Olsen JC, Bunnell BA. Analysis of gene transfer and expression in skeletal muscle using enhanced EIAV lentivirus vectors. Mol Ther 2003; 7: 632-639.
53. Olsen JC. Gene transfer vectors derived from equine infectious anemia virus. Gene Therapy 1998; 5: 1481-1487.
54. Martarano L, Stephens R, Rice N, Derse D. Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing. J Virol 1994; 68: 3102-3111.
55. Stetor SR, Rausch JW, Guo MJ, Burnham JP, Boone LR, Waring MJ et al. Characterization of (+) strand initiation and termination sequences located at the center of the equine infectious anemia virus genome. Biochemistry 1999; 38: 3656-3667.